OTC/Supplement Co-Packaging Policy In The Works At FDA
This article was originally published in The Tan Sheet
Executive Summary
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products